(Q34139329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Signaling and cytotoxic functions of 4-hydroxyalkenals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Shlomo Sasson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Yael Riahi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ofer Shamni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

21 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

E879-86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20858748%20AND%20SRC:MED&resulttype=core&format=json

Increased circulating products of lipid peroxidation in patients with alcoholic liver disease.

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Delayed autoregulation of glucose transport in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-hydroxynonenal and cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Covalent binding of isoketals to ethanolamine phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-Hydroxynonenal signalling to apoptosis in isolated rat hepatocytes: the role of PKC-delta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Inhibition of adenine nucleotide translocator by lipid peroxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-hydroxynonenal (4-HNE) has been widely accepted as an inducer of oxidative stress. Is this the whole truth about it or can 4-HNE also exert protective effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Adaptive response induced by lipid peroxidation products in cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Regulation of rat hepatocyte protein kinase C ? isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: A signaling pathway to modulate vesicular transport of glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-hydroxynonenal from pathology to physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Role of 4-hydroxynonenal and its metabolites in signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Hydroxynonenal and uncoupling proteins: a model for protection against oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Regulation of constitutive neutrophil apoptosis by the alpha,beta-unsaturated aldehydes acrolein and 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Introduction to serial reviews on 4-hydroxy-2-nonenal as a signaling molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Peroxisome proliferator-activated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

The proteasomal system and HNE-modified proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent transcriptional activation of inducible NO synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Circulating oxidized LDL: a biomarker and a pathogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Oxidative modification of LDL: its pathological role in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

21 January 2018

The proteasomal system.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Fat-1 transgenic mice: a new model for omega-3 research

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

PPARdelta regulates glucose metabolism and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Induction of endothelial iNOS by 4-hydroxyhexenal through NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Induction of endothelial apoptosis by 4-hydroxyhexenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-Hydroxy-trans-2-nonenoic acid is a gamma-hydroxybutyrate receptor ligand in the cerebral cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Etheno DNA-base adducts from endogenous reactive species

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Pathological aspects of lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Lipid peroxidation: physiological levels and dual biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Lipid peroxidation: mechanisms, inhibition, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Reactions of 4-hydroxynonenal with proteins and cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

PPAR delta as a therapeutic target in metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

A systemic review of the roles of n-3 fatty acids in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Basic aspects of the biochemical reactivity of 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

An update on products and mechanisms of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Essentiality of fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Aldehydic lipid peroxidation products derived from linoleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

New therapeutic target for metabolic syndrome: PPARdelta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Atherogenesis and the humoral immune response to modified lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic beta-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Arachidonate 12-lipoxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class A scavenger receptor at the level of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

4-hydroxynonenal as a bioactive marker of pathophysiological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010

The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00508.2010